Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke
Crossref DOI link: https://doi.org/10.1007/s10654-016-0122-1
Published Online: 2016-03-05
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wald, Nicholas J.
Luteijn, Johannes Michiel
Morris, Joan K.
Taylor, David
Oppenheimer, Peter
License valid from 2016-03-05